Archive for the ‘Santarus Inc’ Category

Santarus Inc

December 29th, 2010 | Posted in 2011, Santarus Inc

Santarus Inc., San Diego: Saw its shares climb 12% Tuesday, 12/28/10, in pre-market trading after the drug developer said it submitted an application for approval of Rhucin to the FDA.  The company is seeking approval of the drug to treat acute angioedema attacks in patients with hereditary angioedema, a genetic disorder that leads to unpredictable […]